Inflammation and detection: Rethinking the biomarker landscape in gastric cancer

View Full Paper

Ask AI

Bookmark

Authors

Discussion

Research demonstrates potential of inflammatory cytokines as diagnostic markers in gastric cancer, highlighting need for composite panels.

Elevated serum cytokines like IL-6 and IL-8 may serve as reliable biomarkers for gastric cancer diagnosis, improving early detection.
Studies show some cytokines can reach diagnostic utility metrics exceeding 0.70, indicating their potential effectiveness in screening.
Current literature is limited by small sample sizes and variability in design, stressing the need for larger multicenter validation studies.
Integrating cytokine profiling into diagnostic algorithms can enhance the understanding of tumor biology and improve screening strategies.

Parang et al. (2025) studied this question.

View Full Paper

Ask AI

Bookmark

Research demonstrates potential of inflammatory cytokines as diagnostic markers in gastric cancer, highlighting need for composite panels.